Displaying items by tag: division of clinical immunology and rheumatology

UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
The UAB Division of Rheumatology and Immunology and the Division of Cardiovascular Disease look at effects of Allopurinol in healthy adults age 18-40.
UAB is using an online survey to learn more about the relationship between diet and gout.
UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.
U.S. News’ 2016 Best Global Universities ranked UAB among the top 200 in the world and top 75 in the United States, making UAB the highest-ranked university in Alabama.
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
UAB and CreakyJoints, an online, non-profit, patient support community, are launching Arthritis Power — the first patient-centered research registry for arthritis, bone and inflammatory skin conditions — to securely collect health data from tens of thousands of arthritis patients to support future research.
UAB is testing a tablet-based decision aid in hopes of improving outcomes for minority women with lupus and kidney disease
CreakyJoints, an online arthritis support community, and UAB are working to gather information directly from patients through smartphones and tablets to find better ways to treat conditions such as rheumatoid arthritis.
A prestigious textbook on vasculitis, a disorder of the blood vessels, was edited by three members of the UAB faculty.

UAB researchers are launching a study to look at the links between sleep and pain in patients with knee osteoarthritis.

Patients with rheumatoid arthritis have an increased risk for shingles, but new research at UAB indicates that biologics – the newest RA medications – don’t worsen that risk.

Page 4 of 5